Table 3.
E‐diary adherence
| Trial | Expected entriesa | Actual entriesb | e‐diary adherencec | Number of subjects with ≥80% e‐diary adherence |
|---|---|---|---|---|
| 1 (CW) | 3280 | 3187 | 97% | 79/80 (99%) |
| 2 (AD) | 1013 | 963 | 95% | 35/36 (97%) |
| 3 (AD) | 4318 | 3958 | 92% | 72/80 (90%) |
| 4 (GW) | 1960 | 1710 | 87% | 17/24 (71%) |
| 5 (GW) | 1008 | 963 | 96% | 23/24 (96%) |
| 6 (vulvar HSIL) | 1020 | 907 | 89% | 11/12 (92%) |
| Overall mean | 12599 | 11695 | 93% | 237/256 (93%) |
| Median (range) | 93% (87–97%) | 94% (71–98%) |
a
Expected entries of images in e‐diary based on number of patients and treatment days (number of patients x treatment period in days).
b
Actual entries are the imported images of topical drug amount.
c
e‐diary treatment adherence is the percentage of actual entries divided by the expected entries.
AD, atopic dermatitis; CW, cutaneous warts; GW, genital warts; HSIL, high‐grade squamous intraepithelial lesion.